Atara Biotherapeutics (ATRA) Capital Expenditures Growth (3y) (2017 - 2024)
Atara Biotherapeutics (ATRA) Capital Expenditures Growth (3y) (2017 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Atara Biotherapeutics |
134.61 Mn |
126.21 Mn |
392,000.00 |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-78.23% |
| Jun 30, 2024 |
-75.86% |
| Mar 31, 2024 |
-61.33% |
| Dec 31, 2023 |
26.64% |
| Sep 30, 2023 |
-29.56% |
| Jun 30, 2023 |
-28.87% |
| Mar 31, 2023 |
-33.11% |
| Dec 31, 2022 |
-82.71% |
| Sep 30, 2022 |
-34.43% |
| Jun 30, 2022 |
-76.21% |
| Mar 31, 2022 |
21.28% |
| Dec 31, 2021 |
-35.13% |
| Sep 30, 2021 |
-29.50% |
| Jun 30, 2021 |
28.43% |
| Mar 31, 2021 |
-18.81% |
| Dec 31, 2020 |
-35.87% |
| Sep 30, 2020 |
33.77% |
| Jun 30, 2020 |
-20.51% |
| Mar 31, 2020 |
86.05% |
| Dec 31, 2019 |
71.10% |
